HFSA Virtual Board Certification Review 2020
$40
Description
Product Overview & Details for HFSA Virtual Board Certification Review 2020
Videos – Slides – PDF – Questions & Answers
Topics:
*Welcome Introduction I & HFSA Introduction
*Welcome Introduction II
*Welcome Introduction III
*Cardiac Transplantation
1-Advanced HF- Defining the Phenotype and Patient Selection for Advanced Therapies
2-Heart Transplant, Clinical Outcomes and Complications
3-Immunology- The Basics, PRA, Sensitization, Crossmatch
4-Managing Immunosuppression and Drugs
5-Rejection- Cellular and Antibody Mediated
*Heart Failure Fundamentals
1-Cardio-Oncology for the HF Boards
2-Clinico-Pathologic Correlates in HF Images for the HF Boards
3-Device Therapy in Heart Failure
4-Diagnosis and Clinical Assessment
5-Heart Failure Epidemiology and Risk Factors
6-Pathophysiology I- Cellular and Energetic Considerations
7-Pathophysiology II- Hemodynamic, Structural, and Neurohormonal Considerations
*Key Issues in Heart Failure Management
1-Drug Therapy for Chronic HF I
2-Drug Therapy for Chronic HF II
3-Hemodynamics in HF I
4-Hemodynamics in HF II
5-HFpEF- Epidemiology, Risk Factors, Diagnosis, Management (for the boards)
6-Management of Common Arrhythmias in HF (including AF)
7-Management of Comorbidities in Heart Failure
8-Management of the Hospitalized HF Patient
*Shock MCS
1-Cardiogenic Shock Management
2-MCS I- Durable MCS Devices and Outcomes
3-MCS II- Temporary Support Devices and ECMO for the Boards
4-MCS III- MCS Complications and Patient Management
5-MCS IV- Troubleshooting (with HARVI)
*Special Topics in Heart Failure
1-Assessment of Functional Capacity Including Cardiopulmonary Exercise Testing
2-Issues in Chronic HF Disease Management
3-Management of Valvular Heart Disease in Heart Failure
4-Pulmonary Hypertension
5-Specific Etiologies of HF I- Common Etiologies (CAD, ETOH, Peripartum, Myocarditis)
*Specific Heart Failure Symptoms
1-Adult Congenital Heart Disease for the HF Specialist
2-Specific Etiologies of HF II- Inherited HF Syndromes
3-Specific Etiologies of HF III
*Q&A Panel I
*Q&A Panel II
Categories: Cardiology, HFSA
Tags: 2020 Heart Failure Board Review, adult congenital heart disease, advanced heart failure, Advanced Heart Failure Management, Advanced Heart Failure Review, advanced heart failure therapies, Advanced HF, Advanced Therapies, advanced therapies for heart failure, alcoholic cardiomyopathy, Antibody-mediated rejection, arrhythmia management heart failure, arrhythmia management in heart failure, arrhythmias, arrhythmias in heart failure, Atrial Fibrillation in Heart Failure, board certification, Board Certification Review, Board-Review Course, CAD in heart failure, cardiac transplantation, Cardiac Transplantation Education, cardiac transplantation review, cardio-oncology, Cardio-Oncology for Heart Failure, cardio-oncology heart failure, cardiogenic shock, cardiogenic shock management, Cardiology, cardiopulmonary exercise testing, Cardiopulmonary Exercise Testing in Heart Failure, Cellular Rejection, Chronic Heart Failure, chronic heart failure drug therapy, chronic heart failure management, chronic heart failure treatment, Clinical Assessment, clinical outcomes, clinical outcomes in heart transplant, clinico-pathologic correlates in heart failure, comorbidities, Comorbidities in Heart Failure, complications, congenital heart disease, congenital heart disease heart failure, congenital heart disease in adults, congenital heart disease in heart failure, continuing medical education, crossmatch in heart failure, device therapy, device therapy heart failure, device therapy in heart failure, diagnosis, Drug Therapy, Drug Therapy for Heart Failure, durable MCS devices, ECMO, ECMO for Heart Failure, ECMO heart failure, ECMO in heart failure, ECMO training, epidemiology, functional capacity assessment, functional capacity assessment heart failure, HARVI troubleshooting, heart failure, heart failure board review, Heart Failure Certification, Heart Failure Certification Course, heart failure clinical assessment, heart failure comorbidities, heart failure complications, Heart Failure Complications Management, heart failure course, Heart Failure Course PDFs, Heart Failure Course Q&A, Heart Failure Course Slides, Heart Failure Course Videos, heart failure diagnosis, heart failure drug therapy, heart failure epidemiology, heart failure fundamentals, heart failure hemodynamics, heart failure imaging, heart failure immunology, heart failure immunosuppression management, Heart Failure Management, heart failure management strategies, Heart Failure Pathophysiology, heart failure pharmacology, Heart Failure Q&A, Heart Failure Q&A Panels, heart failure review course, heart failure risk factors, Heart Failure Specialist, heart failure specialist certification., heart failure specialist training, Heart Transplant, Heart Transplant Clinical Outcomes, heart transplant complications, heart transplant outcomes, hemodynamics, Hemodynamics in Heart Failure, HF Boards, HFpEF, HFpEF management, HFSA board certification, HFSA board certification review, HFSA board review, HFSA board review course, HFSA Introduction, HFSA Review Course, HFSA Virtual Board Certification Review, HFSA Virtual Board Certification Review 2020, HFSA Virtual Review, HFSA virtual review 2020, hospitalized heart failure, hospitalized heart failure management, Hospitalized HF Patient, immunology, immunology for heart failure, immunology in heart failure, immunosuppression, Immunosuppression management, inherited heart failure, inherited heart failure syndromes, Inherited HF Syndromes, Managing Immunosuppression, managing immunosuppression in heart failure, MCS complications, MCS Devices, Mechanical Circulatory Support, medical education, myocarditis, Neurohormonal Considerations, neurohormonal considerations in heart failure, pathophysiology, peripartum cardiomyopathy, PRA sensitization, pulmonary hypertension, pulmonary hypertension heart failure, Pulmonary Hypertension in Heart Failure, Q&A Panel, Rejection, rejection in heart transplant, specific heart failure etiologies, structural considerations in heart failure, temporary support devices in heart failure, valvular disease heart failure, valvular heart disease, valvular heart disease in heart failure, valvular heart disease management, Virtual Learning, virtual medical education

